The Power List 2016
December 17, 2016
All too often, when considering the movers and shakers in any given field, those who are on their way up are overlooked.
1 min read
False
“Welcome to our December issue. Our Upfront articles this month deal with guidance on laboratory-developed assays, HER2 testing, and quality assurance in Canadian pathology. In My View asks whether we’re letting our fascination with genomics blind us to non-genomic precision medicine tools. Our very special Feature is the 2016 Power List, celebrating the “rising stars” of pathology and laboratory medicine – nominated by you. In Practice discusses the applicability of mass spectrometry to diagnostics, and NextGen explores structured illumination microscopy and microbiome-modeling software. We Sit Down With Greek molecular pathologist Vassilis Gorgoulis.
December 17, 2016
All too often, when considering the movers and shakers in any given field, those who are on their way up are overlooked.
1 min read
December 15, 2016
Sitting Down With... Professor Vassilis Gorgoulis, Director of the Laboratory of Histology-Embryology, Molecular Carcinogenesis Group, Medical School, National and Kapodistrian University of Athens, Greece
1 min read
December 15, 2016
The growing demand for multiple biomarker analysis is presenting diagnostics labs with many new challenges – do you outsource or adapt? And if you keep testing in-house, is the one test–one drug approach even sustainable? Possibly not…
5 min read
December 15, 2016
Mass spectrometry has identified serum protein thresholds that could warn of disease well before symptoms develop
1 min read
December 15, 2016
Exquisite sensitivity and specificity gives MS the edge in newborn hemoglobinopathy screening – is the next step a urine screen for monitoring cardiovascular risk?
1 min read
December 15, 2016
Forewarned is forearmed. A new software tool – MDSINE – predicts how a simplified mouse microbiome reacts to probiotic intervention. Next? The human microbiome
1 min read
December 15, 2016
Structured illumination microscopy could allow pathologists to “see” glomerular structures, aiding the diagnosis of nephrotic disease
1 min read
December 15, 2016
Microfluidic innovations promise a new generation of point-of-care tools for the pathologist
1 min read
December 15, 2016
Exploring the new world of theranostics that integrates cancer diagnosis with treatment
1 min read
December 15, 2016
Has precision medicine’s focus on the genome blinded us to vital non-genomic tools?
1 min read
Dive deeper into the world of pathology. Explore the latest articles, case studies, expert insights, and groundbreaking research.
False
False
False